Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA launches new priority review voucher program for select biopharmas
Diagnostics
MedTech
Grail plans to submit updated Galleri blood test to FDA in 2026
Grail reported it collected positive initial findings from the latest large study of its multi-cancer early detection test.
Conor Hale
Jun 18, 2025 11:45am
Caris Life Sciences ups IPO to raise $494M
Jun 18, 2025 11:00am
Philips unveils new portable ultrasound system for critical care
Jun 17, 2025 1:03pm
Dexcom replaces handheld CGM receivers after missed audio alerts
Jun 17, 2025 10:40am
Wojcicki prevails in 23andMe auction, with final $305M bid
Jun 16, 2025 10:40am
Medtronic adopts familiar name for its diabetes spinout: MiniMed
Jun 12, 2025 10:30am